Robert Desantis Sells 376 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis sold 376 shares of the stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Robert Desantis also recently made the following trade(s):

• On Friday, October 25th, Robert Desantis sold 1,012 shares of Intuitive Surgical stock. The stock was sold at an average price of $514.00, for a total value of $520,168.00.
• On Tuesday, October 29th, Robert Desantis sold 188 shares of Intuitive Surgical stock. The stock was sold at an average price of $506.52, for a total value of $95,225.76.
• On Tuesday, September 10th, Robert Desantis sold 238 shares of Intuitive Surgical stock. The stock was sold at an average price of $477.50, for a total value of $113,645.00.

Intuitive Surgical Stock Up 1.5 %

ISRG opened at $549.95 on Thursday. The firm has a market cap of $195.88 billion, a PE ratio of 88.42, a P/E/G ratio of 5.34 and a beta of 1.38. The business has a fifty day simple moving average of $513.56 and a 200-day simple moving average of $472.07. Intuitive Surgical, Inc. has a fifty-two week low of $304.50 and a fifty-two week high of $552.08.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

ISRG has been the topic of a number of research reports. Stifel Nicolaus increased their price target on Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. Truist Financial raised their target price on Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research report on Monday, October 14th. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a research report on Friday, October 18th. Royal Bank of Canada raised their target price on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Finally, Robert W. Baird raised their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $536.61.

Institutional Investors Weigh In On Intuitive Surgical

Several large investors have recently modified their holdings of the stock. Hazlett Burt & Watson Inc. boosted its stake in shares of Intuitive Surgical by 5.8% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after acquiring an additional 20 shares in the last quarter. Mitchell Mcleod Pugh & Williams Inc. boosted its position in shares of Intuitive Surgical by 4.1% in the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock worth $247,000 after buying an additional 20 shares during the period. Ullmann Wealth Partners Group LLC boosted its position in shares of Intuitive Surgical by 1.6% in the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock worth $653,000 after buying an additional 21 shares during the period. Meeder Advisory Services Inc. boosted its position in shares of Intuitive Surgical by 0.3% in the third quarter. Meeder Advisory Services Inc. now owns 7,386 shares of the medical equipment provider’s stock worth $3,629,000 after buying an additional 22 shares during the period. Finally, One Wealth Management Investment & Advisory Services LLC boosted its position in shares of Intuitive Surgical by 3.4% in the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock worth $310,000 after buying an additional 23 shares during the period. 83.64% of the stock is owned by institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.